Recent Finacing
Recent Raise
Eqalix develops plant-protein-based nanofibrous scaffolds for wound healing and aesthetic dermatology, commercializing regenerative-medicine technologies licensed from the University of Pennsylvania, Drexel University, and Children’s Hospital of Philadelphia.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor